Development of an enzyme-linked immunosorbent assay based on the murine leukemia virus p30 capsid protein

Journal of Virological Methods

Volumn 193, Issue 2, 2013, Pages 332-336

  Wu, Dai Tze ^a   Aiyer, Sriram ^a   Villanueva, Rodrigo A ^a,b   Roth, Monica J ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b UNIVERSIDAD ANDRÉS BELLO   (Chile)

Author keywords

MuLV CA ELISA; P30 CA; Virus normalization

Indexed keywords

ANTIBODY; CAPSID PROTEIN; CORE PROTEIN; MONOCLONAL ANTIBODY; MURINE LEUKEMIA VIRUS P30 CAPSID PROTEIN; NCI ANTIBODY; POLYCLONAL ANTISERUM; RECOMBINANT PROTEIN; RNA DIRECTED DNA POLYMERASE; UNCLASSIFIED DRUG; VIRUS RNA;

ANTIBODY TITER; ARTICLE; BACTERIUM; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE TRANSFER; GOAT; MURINE LEUKEMIA VIRUS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REPORTER GENE; SENSITIVITY ANALYSIS; STATISTICAL MODEL; VIRUS PARTICLE;

MULV CA ELISA; P30 CA; VIRUS NORMALIZATION;

ANIMALS; ANTIBODIES, VIRAL; CAPSID PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GOATS; LEUKEMIA VIRUS, MURINE; SENSITIVITY AND SPECIFICITY; VIRAL LOAD;

EID: 84880736522     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2013.06.020     Document Type: Article

References (11)

1. Åkerström B., Björck L. A physicochemical study of protein G, a molecule with unique immunoglobulin G-binding properties. J. Biol. Chem. 1986, 261:10240-10247.
2. Carmo M., Peixoto C., Coroadinha A.S., Alves P.M., Cruz P.E., Carrondo M.J.T. Quantitation of MLV-based retroviral vectors using real-time RT-PCR. J. Virol. Methods 2004, 119:115-119.
3. Chen C.-C., Rivera A., Ron N., Dougherty J.P., Ron Y. A gene therapy approach for treating T-cell-mediated autoimmune diseases. Blood 2001, 97:886-894.
4. Chesebro B., W W.B., Evans L., Wehrly K., Nishio J., Cloyd M. Characterization of monoclonal antibodies reactive with murine leukemia viruses: use in analysis of strains of Friend MCF and Friend ecotropic murine leukemia virus. Virology 1983, 127:134-148.
5. Felkner R.H., Roth M.J. Mutational analysis of the N-linked glycosylation sites of the SU envelope protein of Moloney murine leukemia virus. J. Virol. 1992, 66:4258-4264.
6. Goff S., Traktman P., Baltimore D. Isolation and properties of Moloney murine leukemia virus mutants: use of a rapid assay for release of virion reverse transcriptase. J. Virol. 1981, 38:239-248.
7. Karpel R.L., Henderson L.E., Oroszlan S. Interactions of retroviral structural proteins with single-stranded nucleic acids. J. Biol. Chem. 1987, 262:4961-4967.
8. Lu R., Limon A., Devroe E., Silver P.A., Cherepanov P., Engelman A. Class II integrase mutants with changes in putative nuclear localization signals are primarily blocked at a postnuclear entry step of human immunodeficiency virus type 1 replication. J. Virol. 2004, 78:12735-12746.
9. Mao A.J., Bechberger J., Lidington D., Galipeau J., Laird D.W., Naus C.C. Neuronal differentiation and growth control of neuro-2a cells after retroviral gene delivery of connexin43. J. Biol. Chem. 2000, 275:34407-34414.
10. Schneider W.M., Wu D.T., Amin V., Aiyer S., Roth M.J. MuLV IN mutants responsive to HDAC inhibitors enhance transcription from unintegrated retroviral DNA. Virology 2012, 426:188-196.
11. Soneoka Y., Cannon P.M., Ramsdale E.E., Griffiths J.C., Romano G., Kingsman S.M., Kingsman A.J. A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucl. Acids Res. 1995, 23:629-633.